CONSORT of participants with OPV status. by Zahid Hasan Khan (6281396)

Subjects:

Determinants of incomplete vaccination. by Zahid Hasan Khan (6281396)

Subjects:

Socio-demographic and medical characteristics of patients with liver cancer. by Ayana Ablayeva (22103708)

Subjects:

A comparison of Paraquat concentrations ^a in various types of plants. by Vivat Keawdounglek (9710710)

Subjects:

Multinomial regression estimates of demographic, resource, and perception factors influencing household food security by gender of decision. by Nancy Ndung’u (21601567)

Subjects:

A comparison of <i>E. coli</i> contamination at Traditional Lanna restaurants before and after the model’s implementation. by Vivat Keawdounglek (9710710)

Subjects:

Characteristics of non-diarrheal stool samples from 1715 children in MAL-ED study. by Haley A. Liakakos (21445884)

Subjects:

Study sites and number of participants enrolled in the KAP and OOP surveys. by Drew B. Cameron (10687420)

Subjects:

Association between socio-demographic and medical parameters and all-cause mortality rates of liver cancer between 2014 and 2023. by Ayana Ablayeva (22103708)

Subjects:

Crude and stage-specific incidence rate of liver cancer per 100,000 over 2014–2023. by Ayana Ablayeva (22103708)

Subjects:

Crude and age-specific mortality to incidence ratios of liver cancer per 100,000 over 2014–2023. by Ayana Ablayeva (22103708)

Subjects:

GLM models for predictors of monthly HTN care costs. by Drew B. Cameron (10687420)

Subjects:

Median monthly care costs, projected visits, and hospitalization costs. by Drew B. Cameron (10687420)

Subjects:

Association of <i>Shigella</i> infections with EE biomarker concentration over time. by Haley A. Liakakos (21445884)

Subjects:

“Laab Nuer Model” for food safety management in handling traditional Lanna cuisine^b. by Vivat Keawdounglek (9710710)

Subjects:

Average cost per visit for HIV and HTN care (absolute vs. relative contributions). by Drew B. Cameron (10687420)

Subjects:

Age- and sex- specific median yearly incidence (A) and mortality (B) rate of liver cancer per 10⁶ population over 2014–2023. by Ayana Ablayeva (22103708)

Subjects:

Crude and age-specific incidence rates (A), all-cause mortality rates (B), and prevalence rates (C) of liver cancer per 100,000 over 2014–2023. by Ayana Ablayeva (22103708)

Subjects:

Crude and type-specific incidence rates (A), all-cause mortality rates (B), and prevalence rates (C) of liver cancer per 100,000 over 2014–2023. by Ayana Ablayeva (22103708)

Subjects:

Age-adjusted annual percent changes (APC) in incidence (A), mortality (B), and prevalence (C) rates per 100,000 over 2014–2023 for both sexes and sex-specific. by Ayana Ablayeva (22103708)

Subjects: